Search results
Showing 76 to 90 of 106 results for magnetic
Laparoscopic insertion of a magnetic bead band for gastro-oesophageal reflux disease (IPG431)
This guidance has been updated and replaced by NICE interventional procedures guidance 585.
This quality standard covers diagnosing and managing lung cancer in adults. It describes high-quality care in priority areas for improvement.
View quality statements for QS17Show all sections
Sections for QS17
NICE has developed a medtech innovation briefing (MIB) on the ATEC breast biopsy system
upper gastrointestinal [GI] endoscopy or combinations of these), what is the accuracy of magnetic resonance cholangiopancreatography...
Magnetic resonance image-guided transcutaneous focused ultrasound for uterine fibroids (IPG413)
Interventional procedures, IPG413 - Issued: November 2011 --> We have moved interventional procedures guidance 413 to become HealthTech guidance 277. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Magnetic resonance image-guided transcutaneous focused ultrasound for uterine fibroids (IPG231)
This guidance has been updated and replaced by NICE HealthTech guidance 277.
Dementia: assessment, management and support for people living with dementia and their carers (NG97)
This guideline covers diagnosing and managing dementia (including Alzheimer’s disease). It aims to improve care by making recommendations on training staff and helping carers to support people living with dementia.
MRI fusion biopsy systems for diagnosing prostate cancer (HTG678)
Evidence-based recommendations on MRI fusion biopsy systems for diagnosing prostate cancer.
Magnetic resonance (MR) image-guided percutaneous laser ablation of uterine fibroids (IPG30)
We have moved interventional procedures guidance 30 to become HealthTech guidance 12. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
NICE has developed a medtech innovation briefing (MIB) on SuperNO2VA for the relief of upper airway obstruction in people with obstructive sleep apnoea .
The PressureWire fractional flow reserve measurement system for coronary artery disease (MIB2)
NICE has developed a Medtech Innovation Briefing (MIB) on the PressureWire fractional flow reserve measurement system
Stretta System for gastro-oesophageal reflux disease (MIB74)
NICE has developed a medtech innovation briefing (MIB) on the Stretta System for gastro-oesophageal reflux disease
This guideline covers assessment, treatment, monitoring and inpatient care for children, young people and adults with eating disorders. It aims to improve the care people receive by detailing the most effective treatments for anorexia nervosa, binge eating disorder and bulimia nervosa.
Discontinued Reference number: GID-IPG10142
Evidence-based recommendations on automated ankle brachial pressure index measurement devices to detect peripheral arterial disease in people with leg ulcers.